EMAIL THIS PAGE TO A FRIEND

Anais da Academia Brasileira de Ciencias

The pilocarpine model of epilepsy: what have we learned?


PMID 19722008

Abstract

The systemic administration of a potent muscarinic agonist pilocarpine in rats promotes sequential behavioral and electrographic changes that can be divided into 3 distinct periods: (a) an acute period that built up progressively into a limbic status epilepticus and that lasts 24 h, (b) a silent period with a progressive normalization of EEG and behavior which varies from 4 to 44 days, and (c) a chronic period with spontaneous recurrent seizures (SRSs). The main features of the SRSs observed during the long-term period resemble those of human complex partial seizures and recurs 2-3 times per week per animal. Therefore, the pilocarpine model of epilepsy is a valuable tool not only to study the pathogenesis of temporal lobe epilepsy in human condition, but also to evaluate potential antiepileptogenic drugs. This review concentrates on data from pilocarpine model of epilepsy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

1538505 Pilocarpine, United States Pharmacopeia (USP) Reference Standard
C11H16N2O2